Prognostic impact of off‐hour liver transplants on graft and survival outcomes
Palaniappan Manickam – 25 May 2012
Liver transplantation for alagille syndrome: The jagged edge
Benjamin L. Shneider – 25 May 2012
Sirolimus: More cause for alarm?
Parul D. Agarwal, Michael R. Lucey – 25 May 2012
Right diaphragmatic defect in hepatic hydrothorax exposed by contrast‐enhanced ultrasonography after radiofrequency ablation
Tomomitsu Matono, Masahiko Koda, Yoshikazu Murawaki – 23 May 2012 – A 68‐year‐old male with liver cirrhosis and hepatocellular carcinoma treated by radiofrequency ablation was hospitalized for right hepatic hydrothorax and ascites. Perflubutane injected into the peritoneal cavity after an ultrasonography contrast agent revealed jet‐like flow from the ascites to a pleural effusion, indicating a diaphragmatic defect. A hepatic hydrothorax was sutured under thoracoscopy and did not recur. An intraperitoneal injection of perflubutane enables a less‐invasive diagnosis of a diaphragmatic defect.
Right diaphragmatic defect in hepatic hydrothorax exposed by contrast‐enhanced ultrasonography after radiofrequency ablation
Tomomitsu Matono, Masahiko Koda, Yoshikazu Murawaki – 23 May 2012 – A 68‐year‐old male with liver cirrhosis and hepatocellular carcinoma treated by radiofrequency ablation was hospitalized for right hepatic hydrothorax and ascites. Perflubutane injected into the peritoneal cavity after an ultrasonography contrast agent revealed jet‐like flow from the ascites to a pleural effusion, indicating a diaphragmatic defect. A hepatic hydrothorax was sutured under thoracoscopy and did not recur. An intraperitoneal injection of perflubutane enables a less‐invasive diagnosis of a diaphragmatic defect.
Role of interleukin‐30 as a modulator of transcription signaling in liver injury
Tetsuji Fujita – 22 May 2012
Reply:
Abhisek Mitra, Jeffry Cutrera, Lopa Mishra, Shulin Li – 22 May 2012
Genetic study of FGF19 receptor variants in gallstone disease
Marcin Krawczyk, Monica Acalovschi, Frank Lammert – 22 May 2012
Lower liver‐related death in African‐American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women
Monika Sarkar, Peter Bacchetti, Audrey L. French, Phyllis Tien, Marshall J. Glesby, Marek Nowicki, Michael Plankey, Stephen Gange, Gerald Sharp, Howard Minkoff, Marion G. Peters, for the Women's Interagency HIV Study (WIHS) – 22 May 2012 – Among individuals with and without concurrent human immunodeficiency virus (HIV), racial/ethnic differences in the natural history of hepatitis C virus (HCV) have been described. African Americans have lower spontaneous HCV clearance than Caucasians, yet slower rates of liver fibrosis once chronically infected.